Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Glass May Help Regenerate Damaged Bone

By HospiMedica staff writers
Posted on 05 Jan 2007
Sufferers from osteoporosis and broken bones may get a boost from a new type of biocompatible glass that shows promise in helping damaged and diseased bone to regenerate.

A team of researchers from Lehigh University (Bethlehem, PA, USA), the University of Alexandria (Egypt), the Instituto Superior Tecnico (Lisbon, Portugal), and other institutions have developed a specially fabricated glass--similar to the spongy interior of bone--that contains interconnected pores that facilitate vascularization. More...
The glass is porous at two scales, containing both nanopores that measure up to 20 nm in diameter and macropores measuring 100 microns or wider. The dual porosity and the pores' interconnectedness enable the glass to form an effective "scaffold” for bone regrowth. This allows the glass to mimic bone's two vital functions, with the nanopores facilitating cell adhesion and crystallization of bone's structural components, and the macropores allowing bone cells to grow inside the glass and form new blood vessels and tissue.

"When you attach the glass to the damaged bone, a layer forms on the surface of the glass that has the same chemical composition as the natural bone,” said Dr. Mohamed Ammar, a dentist and research scientist in the tissue-engineering lab at Alexandria's faculty of dentistry. "The bone cells come to this layer and attach to it, in effect forming a bone matrix around the glass.”

The glass is manufactured in a sol-gel process, a technique that uses relatively low temperatures to prepare glass and inherently promotes nanoporosity. A polymer is added to the solution to achieve interconnected macroporosity. The new material has been successfully tested in laboratory experiments and is now undergoing in vivo tests in Alexandria.

"Thermodynamically, the coexistence of nanopores and macropores is unstable in that the larger pores should absorb the smaller pores,” said team leader Himanshu Jain, Ph.D., director of the Lehigh-based International Materials Institute for New Functionalities in Glass (IMI-NFG), adding that the addition of the polymer caused a phase separation to occur parallel to the sol-to-gel transition, enabling the researchers to overcome the thermodynamic problem.



Related Links:
Lehigh University
University of Alexandria
Instituto Superior Tecnico

Gold Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Endoscopy Display
E190
Open Stapler
PROXIMATE Linear Cutter
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Critical Care

view channel
Image: The researchers grew pancreatic tissue (above) so it incorporated a mesh-like electronic network (red). Cells within the tissue produce insulin (green). (Photo courtesy of Penn Medicine)

‘Cyborg’ Transplants Could Replace Pancreatic Tissue Damaged by Diabetes

Type 1 diabetes destroys insulin-producing islet cells, forcing patients to rely on lifelong insulin therapy or scarce organ transplants. Although lab-grown pancreatic tissue offers a promising alternative,... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.